Results 61 to 70 of about 688 (116)

Acute motor axonal neuropathy associated with the Pfizer SARS-CoV-2 vaccine. [PDF]

Neurol Perspect, 2022
Nicolás-Sánchez FJ, Pujol-Sabaté M, Nicolás-Sarrat FJ, Sarrat-Nuevo RM.   +3 more
europepmc   +1 more source

Diagnosis of Guillain-Barré syndrome and use of Brighton criteria in Peruvian hospitals. [PDF]

Arq Neuropsiquiatr, 2022
Malaga M, Rodriguez-Calienes A, Velasquez-Rimachi V, Alva-Diaz C.   +3 more
europepmc   +1 more source

SARS-CoV-2, a new causative agent of Guillain-Barré syndrome? [PDF]

Med Intensiva (Engl Ed), 2022
Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A.   +3 more
europepmc   +1 more source

[Comment on the article: "Epidemiological and clinical aspects of Guillain-Barré syndrome, 2012-2022"]. [PDF]

Rev Med Inst Mex Seguro Soc
Gómez-Madrigal D.
europepmc   +1 more source

[Guillain-Barré syndrome as an autoimmune neurological manifestation associated with COVID-19: A review of the literature]. [PDF]

Rev Colomb Reumatol, 2022
Naranjo Arango YA, García Henao JP, Farfán Cortés AYAA, Álvarez Correa D.   +3 more
europepmc   +1 more source

Guillain-Barre syndrome associated with previous dengue fever: case report. [PDF]

Rev Peru Med Exp Salud Publica
Sanchez-Landers M, Rodriguez-Benites AF.
europepmc   +1 more source

Oropouche virus - another antecedent event for Guillain-Barré syndrome? [PDF]

Rev Panam Salud Publica
González-Quevedo A, Lestayo O'Farrill Z, Mustelier Becquer R.   +2 more
europepmc   +1 more source

[Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection]. [PDF]

Neurologia, 2020
Barrachina-Esteve O, Palau Domínguez A, Hidalgo-Torrico I, Viguera Martínez ML.   +3 more
europepmc   +2 more sources